Issues and Solutions 2021 - Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions

Raw material requirements in a cGMP environment are often overlooked as a Company develops new products. Depending upon the product being developed, e.g., tablets and capsules vs. biotechnology products to include recombinant microorganisms and gene therapy products
The objective of this FIVE HOUR/DAY, ON-LINE two day highly interactive WCS seminar is to explore raw materials and their requirements – issues and solutions
Compare and Contrast FDA, Health Canada, ICH, USP and EP requirements.
The various raw materials and the user impact
Impact of raw materials in the timely production of a product
Speaker:
Barry A. Friedman, PhD, is a Consultant in the Biotechnology, Regulatory Compliance and Aseptic Processing Arena. Dr. Friedman possesses over 30 years of industrial managerial experience in various aspects of biopharmaceuticals